🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Deepak Kilari

Froedtert Hospital

ORCID: 0000-0002-6999-1901

Also affiliated with Medical College of Wisconsin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study”.

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Cancer(2021)10.1002/cncr.34057

N/A

0.670DataRank · unranked

86 citations

Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam +31 more

Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?

Cancers(2021)10.3390/cancers13205204

N/A

0.483DataRank · unranked

24 citations

Lavannya Sabharwal, Vindhya Udhane, Cristina Maranto, Peter S. LaViolette, Kenneth Jacobsohn +8 more

Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer

Cancers(2022)10.3390/cancers14194714

N/A

0.330DataRank · unranked

8 citations

Meijun Du, Alex C. Soupir, Liewei Wang, Winston Tan, Krishna R. Kalari +6 more

Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes

European Urology Oncology(2025)10.1016/j.euo.2025.01.002

N/A

0.292DataRank · unranked

6 citations

Abuzar Moradi Tuchayi, Soon Khai Low, Ali T. Arafa, Laura Graham, Roman Gulati +15 more

Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0224-4

N/A

0DataRank · unranked

27 citations

Yijun Tian, Winston Tan, Liewei Wang, Liguo Wang, Deepak Kilari +4 more

5hmC-profiles in Puerto Rican Hispanic/Latino men with aggressive prostate cancer

Frontiers in Oncology(2025)10.3389/fonc.2025.1541878

N/A

0DataRank · unranked

1 citations

Mousa Almubarak, Jaime Matta, Carmen Ortíz, Jarline Encarnación-Medina, Gilberto Ruiz-Deyá +10 more

Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial

Practical Radiation Oncology(2021)10.1016/j.prro.2021.03.006

N/A

0DataRank · unranked

6 citations

Meena Bedi, Deepak Kilari, Kathryn Bylow, John Burfeind, Candice Johnstone +8 more

DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.129

N/A

0DataRank · unranked

0 citations

Richard E. Green, Joseph J. Park, Olesia Kellezi, Clara Hwang, Pedro C. Barata +15 more

5-hydroxymethylcytosine sequencing of plasma cell-free DNA identifies epigenomic features in prostate cancer patients receiving androgen deprivation therapies

Communications Medicine(2025)10.1038/s43856-025-00783-0

N/A

0DataRank · unranked

6 citations

Chiang‐Ching Huang, Shane Huang, Yijun Tian, Jinyong Huang, Amirreza Bitaraf +12 more